These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 150362)

  • 1. Immune status in Crohn's disease. 2. Originally unimpaired primary cell mediated immunity in vitro.
    Auer IO; Buschmann C; Ziemer E
    Gut; 1978 Jul; 19(7):618-26. PubMed ID: 150362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired anamnestic cellular immune response in patients with Crohn's disease.
    Meuwissen SG; Schellekens PT; Huismans L; Tytgat GN
    Gut; 1975 Nov; 16(11):854-60. PubMed ID: 1193415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune status in Crohn's disease. I. Leukocyte and lymphocyte subpopulations in peripheral blood.
    Auer IO; Wechsler W; Ziemer E; Malchow H; Sommer H
    Scand J Gastroenterol; 1978; 13(5):561-71. PubMed ID: 309171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune status in Crohn's disease. 3. Peripheral blood B lymphocytes, enumerated by means of F(ab)2-antibody fragments, Null and T lymphocytes.
    Auer IO; Götz S; Ziemer E; Malchow H; Ehms H
    Gut; 1979 Apr; 20(4):261-8. PubMed ID: 312753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral blood mononuclear cells from patients with inflammatory bowel disease exhibit normal function in the allogeneic and autologous mixed leukocyte reaction and cell-mediated lympholysis.
    MacDermott RP; Bragdon MJ; Thurmond RD
    Gastroenterology; 1984 Mar; 86(3):476-84. PubMed ID: 6229444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of zinc status and malnutrition on immunological function in Crohn's disease.
    Ainley C; Cason J; Slavin BM; Wolstencroft RA; Thompson RP
    Gastroenterology; 1991 Jun; 100(6):1616-25. PubMed ID: 1902189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T lymphocyte subsets in inflammatory bowel disease: peripheral blood.
    Selby WS; Jewell DP
    Gut; 1983 Feb; 24(2):99-105. PubMed ID: 6221976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anergy to dinitrochlorobenzene and depression of T-lymphocytes in Crohn's disease and ulcerative colitis.
    Meyers S; Sacher DB; Taub RN; Janowitz HD
    Gut; 1976 Nov; 17(11):911-5. PubMed ID: 1087263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Selected cellular immunity parameters in patients with Lesniowski-Crohn disease].
    Słotwiński R; Szczygieł B; Lech G; Kolewska D; Wasik M
    Pol Merkur Lekarski; 1997 Nov; 3(17):224-7. PubMed ID: 9523477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phagocytosis, killing, lymphocyte-mediated antibacterial activity, serum autoantibodies, and plasma endotoxins in inflammatory bowel disease.
    Caradonna L; Amati L; Lella P; Jirillo E; Caccavo D
    Am J Gastroenterol; 2000 Jun; 95(6):1495-502. PubMed ID: 10894586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mixed-lymphocyte reaction as a measure of immunological competence of lymphocytes from patients with Crohn's disease.
    Richens ER; Williams MJ; Gough KR; Ancill RJ
    Gut; 1974 Jan; 15(1):24-8. PubMed ID: 4274413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow cytometric analysis of peripheral blood lymphocytes in ulcerative colitis and Crohn's disease.
    Senju M; Hulstaert F; Lowder J; Jewell DP
    Gut; 1991 Jul; 32(7):779-83. PubMed ID: 1677342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in the immunoglobulin synthesis by peripheral blood lymphocytes in Crohn's disease and ulcerative colitis.
    Verspaget HW; Peña AS; Weterman IT; Lamers CB
    Digestion; 1987; 38(4):245-53. PubMed ID: 3447918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of anergy to dinitrochlorobenzene (DNCB) in inflammatory bowel disease: family and postoperative studies.
    Meyers S; Sachar DB; Taub RN; Janowitz HD
    Gut; 1978 Apr; 19(4):249-52. PubMed ID: 648933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-cell activation in Crohn's disease. Increased levels of soluble interleukin-2 receptor in serum and in supernatants of stimulated peripheral blood mononuclear cells.
    Mueller C; Knoflach P; Zielinski CC
    Gastroenterology; 1990 Mar; 98(3):639-46. PubMed ID: 2298368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutrophil-lymphocyte ratio: a controversial marker in predicting Crohn's disease severity.
    Gao SQ; Huang LD; Dai RJ; Chen DD; Hu WJ; Shan YF
    Int J Clin Exp Pathol; 2015; 8(11):14779-85. PubMed ID: 26823804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoresponsiveness in ulcerative colitis and Crohn's disease--effect of colectomy and suppression of disease activity.
    Lyanga J; Davis P; Thomson AB
    West J Med; 1988 Apr; 148(4):421-5. PubMed ID: 3388844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoregulatory function of human intestinal mucosa lymphoid cells: evidence for enhanced suppressor cell activity in inflammatory bowel disease.
    Fiocchi C; Youngman KR; Farmer RG
    Gut; 1983 Aug; 24(8):692-701. PubMed ID: 6223862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of impaired activation of lymphocytes by suppressive factor in Crohn's disease patients.
    Watanabe M; Tsuru S; Aiso S; Hibi T; Yoshida T; Asakura H; Zinnaka Y; Tsuchiya M
    J Clin Lab Immunol; 1984 May; 14(1):29-34. PubMed ID: 6748044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T-cell immunoregulation in patients with inflammatory bowel disease. II. Enhanced suppressor T-cell activity in ulcerative colitis.
    Kramer JK; Depew WT; Szewczuk MR
    J Clin Lab Immunol; 1988 Jan; 25(1):19-27. PubMed ID: 2968458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.